🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine the safety and effectiveness of v...
Status
Completed
Location
University of Arizona
Start Date
2004-06
Trial ID
NCT00093093
Treatments Being Tested
This observational, multi-center, open-label study will evaluate the progno...
Status
Completed
Location
Multiple Locations
Start Date
2009-05
Trial ID
NCT01283074
GSK2336805 is a novel hepatitis C virus (HCV) non-structural 5A (NS5A) inhi...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-08-01
Trial ID
NCT01648140
Treatments Being Tested
This study will evaluate the efficacy and safety of capecitabine (Xeloda) i...
Status
Completed
Location
Multiple Locations
Start Date
2005-01
Trial ID
NCT02576964
Treatments Being Tested
Bile acids regulating farnesoid X receptor (FXR) interact with hepatitis B ...
Status
Completed
Location
Scientia Clinical Research Limited
Start Date
2017-09-21
Trial ID
NCT03272009
Treatments Being Tested
Primary objective: Compare Pegasys RGT overall response rate (i.e., HBeAg s...
Status
Unknown
Location
Shinchon Severance Hospital
Start Date
2012-09
Trial ID
NCT01456312
Treatments Being Tested
Currently, seven medications are approved for the treatment of hepatitis B:...
Status
Unknown
Location
Research Center for Biological Therapy, The Institute of Translational Hepatology, Beijing 302 Hospital
Start Date
2011-07
Trial ID
NCT01906580
Treatments Being Tested
This study evaluates whether addition of Peginterferon alfa-2a to CHB Patie...
Status
Unknown
Location
Kaifeng Central Hospitl
Start Date
2016-09
Trial ID
NCT02894918
Treatments Being Tested
This study seeks to evaluate the safety and efficacy of taking fluvastatin ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2010-02
Trial ID
NCT00814606
Treatments Being Tested
REP 9AC (REP 2055) is a nucleic acid polymer (NAP) with entry and post-entr...
Status
Completed
Location
Farabi General Hospital
Start Date
2011-08
Trial ID
NCT02646189
Treatments Being Tested